Loading... Please wait...

Our Newsletter

Lonidamine | Glycolysis inhibitor

  • Lonidamine.jpg
  • Lonidamine, 400x400px, png
Catalog #:

Product Description

Lonidamine is an orally-available, indazole-based inhibitor of glycolysis by the inactivation of hexokinase. Lonidamine is believed to increase apoptosis and in in vitro models has displayed markers of mitochondrial membrane depolarization, cytochrome C release, phosphatidylserine externalization, and DNA fragmentation. In support of apotosis induction, caspase activity was found to be enhanced by Lonidamine in LNCaP cells. (1)

In separate studies, lonidamine was found to act of mitochondra to induce apoptosis by dissipating the inner transmembrane potential and the release of key apoptotic factors. (2)

Technical information:

Chemical Formula:   C15H10Cl2N2O2
CAS #:   50264-69-2
Molecular Weight:   321.16
Purity:   > 98%
Appearance:   white
Chemical Name:   1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid
Solubility:   Up to 100 mM in DMSO
Synonyms:   0

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Brawer et al., Lonidamine: Basic Science and Rationale for Treatment of Prostatic Proliferative Disorders. Rev. Urol. 2005, 7, suppl. 7, S21-S26. Pubmed ID: 16986057
2. Ravagnan et al., Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited eff?€ect on the mitochondrial permeability transition pore. Oncogene, 1999, 18, 2537-2546. Pubmed ID: 10353597

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the Lonidamine | Glycolysis inhibitor to your wish list.

You Recently Viewed...